Table 1.
Patient numbers and age at baseline and follow-up.
Study month | Number of patients | Age in years (mean ± SD) | ||
---|---|---|---|---|
M | F | M | F | |
0 | 63 | 31 | 62.05 ± 12.47 | 59.77 ± 16.04 |
1–6 | 49 | 28 | 62.70 ± 12.66 | 60.35 ± 16.28 |
7–12 | 43 | 23 | 63.33 ± 12.98 | 58.77 ± 16.70 |
13–18 | 27 | 14 | 63.79 ± 13.15 | 58.82 ± 14.25 |
19–24 | 20 | 11 | 64.00 ± 13.96 | 58.29 ± 15.46 |
Given are the numbers of patients (M, male/F, female) left at the respective time periods of sample collection for glycomic profiling and/or determination of clinical parameters as described in the experimental section.